Comparison of high-dose with low-dose aspirin in patients with mechanical heart valve replacement treated with oral anticoagulant

Circulation

Volumn 94, Issue 9, 1996, Pages 2113-2116

  Altman, Raúl ^a,c   Rouvier, Jorge ^a   Gurfinkel, Enrique ^a   Scazziota, Alejandra ^a   Turpie, Alexander G G ^b  

^a Sanatorio Guemes   (Argentina)

^b MCMASTER UNIVERSITY   (Canada)

^c Ctro de Estud Medicos Bioquimicos   (Argentina)

Author keywords

anticoagulants; aspirin; embolism; prosthesis; valves

Indexed keywords

ACENOCOUMAROL; ACETYLSALICYLIC ACID;

ADULT; AGED; ANTICOAGULATION; ARTICLE; BLEEDING; CLINICAL TRIAL; EMBOLISM; FEMALE; FIBRINOLYTIC THERAPY; HEART VALVE REPLACEMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; VALVULAR HEART DISEASE;

EID: 0029851202     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.94.9.2113     Document Type: Article

References (14)

1. Stein PD, Kantrowitz A. Antithrombotic therapy in mechanical and biological prosthetic heart valves and saphenous vein bypass grafts. Chest. 1992;102(suppl):445S-455S.
2. British Society for Haematology. Guidelines on oral anticoagulation. J Clin Pathol. 1990;43:177-183.
3. Altman R, Boullon F, Rouvier J. Raca R, de la Fuente L, Favaloro R. Aspirin and prophylaxis of thromboembolic complications in patients with substitute heart valves. J Thorac Cardiovasc Surg. 1976; 72:127-129.
4. Sullivan JM, Harken DE, Gorlin R. Pharmacologic control of thromboembolic complications of cardiac-valve replacement. N Engl J Med. 1971;248:1391-1394.
5. Dale J, Myhre E, Storstein O, Stormorken H, Efskind L. Prevention of arterial thromboembolism with acetylsalicylic acid: a controlled clinical study in patients with aortic ball valves. Am Heart J. 1977; 94:101-111.
6. Chesebro JH, Fuster V, Elveback LR, McGoon DC, Pluth JR, Puga FJ, Wallace RB, Danielson GK, Orszulak TA, Piehler JM, Schaff HV. Trial of combined warfarin plus dipyridamole or aspirin therapy in prosthetic heart valve replacement: danger of aspirin compared with dipyridamole. Am J Cardiol 1983;51:1537-1541.
7. Altman R, Rouvier J, Gurfinkel E, D'Ortencio O, Manzanel R, de la Fuente L, Favaloro R. Comparison of two levels of anticoagulant therapy in patients with substitute heart valves. J Thorac Cardiovasc Surg. 1991;101:427-431.
8. Turpie AGG, Gent M, Laupacis A, Latour Y, Gunstensen J, Basile F, Klimer M, Hirsh J. A comparison of aspirin with placebo in patients treated with warfarin after heart-valve replacement. N Engl J Med. 1993;329:524-529.
9. Hirsh J, Dalen JE, Fuster V, Harker LB, Patrono C, Roth G. Aspirin and other platelet-active drugs: the relationships among dose, effectiveness, and side effects. Chest. 1995;108(suppl):247S-257S.
10. Stein PD, Alpert JS, Copeland J, Dalen JE, Goldman S, Turpie AGG. Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves. Chest. 1995;108(suppl):371S-379S.
11. Hoogendijk EMG, ten Cate JW. Aspirin and platelets. Lancet. 1980; 1:93-94.
12. Jakubowski JA, Stampfer MJ, Vaillancourt R, Deykin D. Cumulative antiplatelet effect of low-dose enteric coated aspirin. Br J Haematol. 1982;60:635-642.
13. Meade TW, Miller GJ. Combined use of aspirin and warfarin in primary prevention of ischemic heart disease in men at high risk. Am J Cardiol. 1995;75:23B-26B.
14. Altman R, Rouvier J, Gurfinkel E. Oral anticoagulant treatment with and without aspirin. Thromb Haemost. 1995;74:506-510.